Regulatory & Standards
16 March 2023
Rupa Pike, Senior Director of
8 March 2023
Adaptimmune Theraputics and TCR2 Theraputics
28 February 2023
Mesoblast has announced that the
24 February 2023
UniQure and its global biotechnology
15 February 2023
Heartseed Inc (Tokyo, Japan) and
8 February 2023
Leading late-stage biotechnology company Rocket
7 February 2023
The Janssen Pharmaceutical Companies of
1 February 2023
NICE has announced the approval